user

REDUCTION IN INCONTINENCE PRODUCT USE AND ASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER

被引：0
|
作者：
Schulte-Baukloh, H. [1 ]
Farrelly, E. [2 ]
Lorenzo-Gomez, M. [3 ]
Boroujerdi, A. [4 ]
Hamid, R. [5 ]
机构：
[1] Charite, Urol Practice, Berlin, Germany
[2] Sodersjukhuset Stockholm South Gen Hosp, Stockholm, Sweden
[3] Univ Salamanca, Salamanca, Spain
[4] Allergan Plc, Dublin, Ireland
[5] Univ Coll London Hosp, London, England
来源：
NEUROUROLOGY AND URODYNAMICS | 2020年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [11] OnabotulinumtoxinA for the treatment of idiopathic overactive bladder is effective and safe for repeated use
    Carlson, Kevin
    Civitarese, Andrea
    Baverstock, Richard
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (05): : E179 - E183
  • [12] Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder
    Hoebeke, Piet
    Hittelman, Adam
    Jenkins, Brenda
    Geib, Till
    Titanji, Wilson
    Bogaert, Guy
    JOURNAL OF PEDIATRIC UROLOGY, 2024, 20 (04) : 600e1 - 600e8
  • [13] Real-world onabotulinumtoxinA treatment patterns in patients with overactive bladder
    Chughtai, Bilal
    Ricker, Christine N.
    Boldt, Ryan J.
    Elterman, Dean
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (02) : 396 - 406
  • [14] ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES URINARY INCONTINENCE AND QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS REGARDLESS OF INCONTINENCE SEVERITY AT BASELINE
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    Drake, M.
    Joshi, M.
    Magyar, A.
    Herschorn, S.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S109 - S110
  • [15] REDUCTION IN URINARY INCONTINENCE AND IMPROVEMENT IN QUALITY OF LIFE WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS IS UNAFFECTED BY THE USE OF CLEAN INTERMITTENT CATHETERIZATION OR THE PRESENCE OF URINARY TRACT INFECTION
    Sussman, David
    Gruenenfelder, Jennifer
    Schulte-Baukloh, Heinrich
    Guard, Steven
    Zheng, Yan
    Everaert, Karel
    JOURNAL OF UROLOGY, 2014, 191 (04): : E883 - E884
  • [16] LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE FOLLOWING ONABOTULINUMTOXINA TREATMENT IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE
    Sand, P. K.
    Khullar, V.
    Joshi, M.
    Zheng, Y.
    Nitti, V.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S61 - S62
  • [17] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE
    Sand, P. K.
    Khalaf, K. M.
    Yan, X.
    Globe, D.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192
  • [18] Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment
    Hoag, N.
    Plagakis, S.
    Pillay, S.
    Edwards, A. Wilson
    Gani, J.
    BJU INTERNATIONAL, 2016, 117 : 68 - 68
  • [19] Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment
    Hoag, Nathan
    Plagakis, Sophie
    Pillay, Samantha
    Edwards, Ailsa Wilson
    Gani, Johan
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (05) : 1377 - 1381
  • [20] RISK FACTORS ASSOCIATED WITH FECAL INCONTINENCE IN PATIENTS WITH OVERACTIVE BLADDER
    Lim, Caitlin
    Cohn, Joshua
    Kowalik, Casey
    Kaufman, Melissa
    Dmochowski, Roger
    Reynolds, Stuart
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S584 - S585
12345